RXRX
Recursion Pharmaceuticals Inc
Price:  
3.08 
USD
Volume:  
14,764,938.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RXRX Stock Forecast & Price Target

RXRX Stock Price Forecast

The average stock forecast for Recursion Pharmaceuticals Inc (RXRX) in the next 12 months is 6.20 USD. This price target corresponds to an upside of 114.70%. The range of stock forecasts for RXRX is 3.03 - 10.50 USD. Based on the ratings of 14 analysts, the consensus recommendation for RXRX is BUY.
Target Low Average Median High
Price (USD) 3.03 6.20 5.87 10.50
Upside 4.84% 114.70% 102.94% 263.32%

Recommendation Trends

The latest consensus rating for RXRX is "BUY". This is the average recommendation of 14 analysts: 0 strong sell, 0 sell, 6 hold, 6 buy, 2 strong buy. In the previous period, 14 analysts also majorly recommmended "BUY" for RXRX.

RXRX Financial Stock Forecast

Revenue This Year
66.03M
-11.58%
from 74.68M
Revenue Next Year
84.97M
28.67%
from 66.03M
EPS This Year
-0.94
-23.02%
from -1.22
EPS Next Year
-0.91
-2.54%
from -0.94